Danielsson A, Björk I
Biochem J. 1981 Feb 1;193(2):427-33. doi: 10.1042/bj1930427.
The interaction between bovine antithrombin, a plasma proteinase inhibitor, and heparin species of different molecular weights was studied. A commercial heparin preparation was divided by gel chromatography into a number of fractions with average molecular weights ranging from 6000 to 34700. Each of these fractions was further fractionated by affinity chromatography on matrix-bound antithrombin. In the latter procedure, those heparin fractions that had molecular weights lower than about 14000 were separated into three peaks. The material in the first of these was not adsorbed on the column, and the other two peaks corresponded to the low-affinity and high-affinity peaks described previously. In contrast, high-molecular-weight heparin samples gave only the low-affinity and high-affinity fractions. U.v. difference absorption studies showed that the non-adsorbed heparin fraction bound to antithrombin in solution with a binding constant at physiological ionic strength only slightly lower than that of low-affinity heparin. The division between the two fractions thus is arbitrary and only dependent on the conditions selected for the affinity-chromatography experiment. Stoicheiometries and binding constants for the binding of several high-affinity heparin species to antithrombin were determined by fluorescence titrations. High-affinity heparin fractions of equal elution positions in the beginning of the peaks of the affinity chromatographies, but with different molecular weights, showed stoicheiometries that were not experimentally distinguishable from 1:1 and also had no appreciable differences in binding constants. However, the anticoagulant activities, calculated on a molar basis, of these fractions increased markedly with molecular weight, a behaviour that thus cannot be explained by differences in the binding of the fractions to antithrombin. In contrast, high-affinity samples of similar molecular weights, which were eluted at increasing ionic strengths from matrix-linked antithrombin, were found to have an increasing proportion of chains with two binding sites for antithrombin and also to have progressively higher binding constants. These binding properties at least partly explain the increasing anticoagulant activities that were observed for these fractions.
研究了血浆蛋白酶抑制剂牛抗凝血酶与不同分子量肝素种类之间的相互作用。一种商业肝素制剂通过凝胶色谱法被分成若干平均分子量范围为6000至34700的级分。这些级分中的每一个进一步通过在基质结合的抗凝血酶上的亲和色谱法进行分级分离。在后者的过程中,那些分子量低于约14000的肝素级分被分离成三个峰。其中第一个峰中的物质未吸附在柱上,另外两个峰对应于先前描述的低亲和力峰和高亲和力峰。相反,高分子量肝素样品仅给出低亲和力和高亲和力级分。紫外差示吸收研究表明,未吸附的肝素级分在生理离子强度下与溶液中的抗凝血酶结合,其结合常数仅略低于低亲和力肝素。因此,这两个级分之间的划分是任意的,仅取决于为亲和色谱实验选择的条件。通过荧光滴定法测定了几种高亲和力肝素种类与抗凝血酶结合的化学计量比和结合常数。在亲和色谱峰开始时具有相同洗脱位置但分子量不同的高亲和力肝素级分,其化学计量比在实验上与1:1无法区分,并且结合常数也没有明显差异。然而,这些级分以摩尔为基础计算的抗凝活性随分子量显著增加,因此这种行为不能用级分与抗凝血酶结合的差异来解释。相反,从基质连接的抗凝血酶在增加的离子强度下洗脱的类似分子量的高亲和力样品,发现具有两个抗凝血酶结合位点的链的比例增加,并且结合常数也逐渐升高。这些结合特性至少部分解释了观察到的这些级分的抗凝活性增加。